home / stock / dtc:cc / dtc:cc news

DTC:CC News and Press, Defence Therapeutics Inc. Class A From 10/06/23

Stock Information
Company Name: Defence Therapeutics Inc. Class A
Stock Symbol: DTC:CC
Market: CNQC
Website: defencetherapeutics.com
Menu
DTC:CC DTC:CC Quote DTC:CC Short DTC:CC News DTC:CC Articles DTC:CC Message Board
Get DTC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC:CC - Defence to Present Three of Its Leading Products at the Upcoming Festival of Biologics in Basel, Switzerland

Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is ...
DTC:CC - Defence's Accum(R)-mRNA Lipid Nanoparticles Elicit Antibody Response 2X Stronger than Standard mRNA Vaccines

Vancouver, British Columbia--(Newsfile Corp. - September 25, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, ...

DTC:CC - Defence to Collaborate with Native Ads for Marketing Campaign

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2023) - Defence Therapeutics Inc.  (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technolo...

DTC:CC - Defence's Broad and Versatile Accum(R) Technology Platform Focus on Cancer Therapeutics

Vancouver, British Columbia--(Newsfile Corp. - September 12, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), one of the leading Canadian biotechnology companies, is pleased to announce its continuation to bringing innovative strategies a...
DTC:CC - Defence's Innovative Therapeutics Featured on Viewpoint with Dennis Quaid

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company ") a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announ...

DTC:CC - Defence Successfully Completes the First Milestone of Its Collaboration Agreement with Orano

Vancouver, British Columbia--(Newsfile Corp. - July 18, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company ") is pleased to announce that it has successfully reached the first milestone established in the Collaboration Agreement with Orano Supp...

DTC:CC - RETRANSMISSION: Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology

Vancouver, British Columbia--(Newsfile Corp. - July 5, 2023) - Defence Therapeutics Inc. (" Defence " or the " Company ") a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint with Denn...
DTC:CC - Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnology

Vancouver, British Columbia--(Newsfile Corp. - July 4, 2023) - Defence Therapeutics Inc. (" Defence " or the " Company ") a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint with D...

DTC:CC - Defence Patent Portfolio at the Forefront of Success

Vancouver, British Columbia--(Newsfile Corp. - June 28, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company ") is a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies. Sitting at the core ...

DTC:CC - Defence's Proprietary Accum(TM) Technology for Delivery of CRISPR/Cas Genome-Editing Complexes Patent Application Published

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce...
Previous 10 Next 10